We are live on ! Find out more
CC

Caxton Corporation Portfolio holdings

AUM $4.02M
1-Year Est. Return 256.08%
This Fund
S&P 500
This Quarter Est. Return
-41.88%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$118M
AUM Growth
Cap. Flow
+$176M
Cap. Flow %
149.15%
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 99.78%
2 Financials 0.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDGL icon
1
Madrigal Pharmaceuticals
MDGL
$12.6B
$118M 99.78%
+675,196
New +$176M
HALL
2
DELISTED
Hallmark Financial Services, Inc.
HALL
$255K 0.22%
+2,790
New +$252K

Similar funds

Caxton Corporation's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Caxton Corporation, which disclosed 2 positions worth $118M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Madrigal Pharmaceuticals: 675,196 shares worth $118M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, followed by Financials.

  • Caxton Corporation's largest Q2 2013 buy was Madrigal Pharmaceuticals: 675,196 shares worth $118M.
  • Caxton Corporation's ten largest holdings make up 100% of its $118M portfolio in Q2 2013.
  • Caxton Corporation disclosed 2 positions in Q2 2013, its first 13F filing on record.

Based on Caxton Corporation's 13F filing for Q2 2013, filed 14 Aug 2013.